VG Life Sciences Inc.
VGLS
$0.00
$0.000.00%
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 22.90K | 4.30K | 30.10K | 34.00K | 53.80K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 17.40K | 35.10K | 62.00K | 212.30K | 6.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 40.30K | 39.40K | 92.10K | 246.30K | 60.50K |
|
|
|||||
| Total Current Assets | 40.30K | 39.40K | 92.10K | 246.30K | 60.50K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.12M | 1.12M | 1.17M | 1.32M | 1.14M |
|
|
|||||
| Total Accounts Payable | 837.00K | 726.10K | 684.70K | 710.30K | 866.10K |
| Total Accrued Expenses | 300.10K | 327.60K | 347.40K | 599.40K | 447.70K |
| Short-term Debt | 3.38M | 4.09M | 4.25M | 3.86M | 3.70M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 940.00K | 812.70K | 613.00K | 658.10K | 1.30M |
| Total Other Current Liabilities | 940.00K | 812.70K | 613.00K | 658.10K | 1.30M |
| Total Current Liabilities | 5.46M | 5.96M | 5.89M | 5.83M | 6.31M |
|
|
|||||
| Total Current Liabilities | 5.46M | 5.96M | 5.89M | 5.83M | 6.31M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 3.38M | 4.09M | 4.25M | 3.86M | 3.70M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.46M | 5.96M | 5.89M | 5.83M | 6.31M |
|
|
|||||
| Common Stock & APIC | 104.86M | 103.34M | 102.05M | 100.80M | 99.70M |
| Retained Earnings | -109.84M | -108.83M | -107.43M | -105.97M | -105.54M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -4.98M | -5.49M | -5.38M | -5.17M | -5.84M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
|
|
|||||
| Total Common Equity | -4.98M | -5.49M | -5.38M | -5.17M | -5.84M |
| Total Preferred Equity | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Total Minority Interest | 638.70K | 647.30K | 655.90K | 664.50K | 673.10K |
| Total Equity | -4.34M | -4.84M | -4.73M | -4.51M | -5.17M |
|
|
|||||
